Drug-induced sensorineural deafness caused by antithyroid drugs: a rare side effect
Authors:
- 1 September 2010
- journal article
- case report
- Published by SAGE Publications in Journal of the Royal College of Physicians of Edinburgh
- Vol. 40 (3) , 219-220
Abstract
Acute ototoxicity is a rare but important complication of antithyroid drugs. Although previous cases have been reported in the medical literature, these cases occurred in younger patients with serological evidence of lupus-like syndrome with positive antidouble-stranded deoxyribonucleic acid and antineutrophil cytoplasmic antibodies. We describe the case of a 68-year-old Caucasian male who developed deafness and tinnitus one week after being prescribed carbimazole. The management options include stopping the culprit drug, treatment with immunosuppressive drugs and referring the patient for urgent thyroidectomy. Healthcare professionals who prescribe antithyroid drugs should be aware of this rare but potentially serious complication, so that early drug withdrawal and referral for surgery can be considered.Keywords
This publication has 6 references indexed in Scilit:
- The incidence of autoimmune thyroid disease: a systematic review of the literatureClinical Endocrinology, 2008
- Progressive Bilateral Sensorineural Hearing Loss Induced by an Antithyroid DrugORL, 2004
- Propylthiouracil-Induced Sensorineural Hearing Loss Associated with Antineutrophil Cytoplasmic AntibodiesEndocrine Practice, 2004
- Myeloperoxidase-antineutrophil cytoplasmic antibody-associated sensorineural hearing lossAuris Nasus Larynx, 2001
- Drug points: Hearing loss and tinnitus with carbimazoleBMJ, 1994
- Propylthiouracil Hypersensitivity with Circumstantial Evidence for Drug-Induced Reversible Sensorineural Deafness: A Case ReportHormone Research, 1991